A systematic proteomic profiling and pathway analysis of protein biomarkers in diabetic retinopathy with subsequent validation of the IL-6 upstream regulator
- 14 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (1) , 801-815
Abstract
Purpose Diabetic retinopathy (DR) is a leading cause of irreversible blindness worldwide. Identifying risk factors associated with DR development and progression is crucial for improving treatment efficacy. Although proteomic changes in DR have been extensively studied, the results remain equivocal. Hence, this study aims to summarize and identify potential diagnostic or prognostic markers for DR. In addition, the upstream regulator responsible for protein deregulation of this disease was also validated. Methods We systematically analyzed the current literature on proteomic profile changes in DR, followed by pathway analysis identification. To validate the protein level changes, ELISA was performed from serum samples collected from 27 patients with DR and 25 healthy controls. Results Our analysis revealed that 1 candidate marker (afamin [AFM]) distinguished non-proliferative diabetic retinopathy (NPDR) from type 2 diabetic patients with no diabetic retinopathy/controls, 65 candidate markers distinguished proliferative diabetic retinopathy (PDR) from NPDR, 1 candidate marker (thyroid receptor-interacting protein 11 [TRIP11]) distinguished PDR from PDR-DME/DME, and 3 candidate markers for therapeutic evaluation of PDR. Our results pinpoint that inflammatory response, which IL-6 mainly modulated, is responsible for the changes of proteomic profiles identified in DR. This was also validated by ELISA analysis, indicating that IL-6 could be potentially useful for diagnosing DR. Conclusion We report a comprehensive patient-based proteomic approach to identify potential biomarkers for DR diagnosis, prognosis, and treatment evaluation.Keywords
This publication has 51 references indexed in Scilit:
- Identification of new pathogenic candidates for diabetic macular edema using fluorescence‐based difference gel electrophoresis analysisDiabetes/Metabolism Research and Reviews, 2013
- Verification of Multimarkers for Detection of Early Stage Diabetic Retinopathy Using Multiple Reaction MonitoringJournal of Proteome Research, 2013
- Proteomic analysis of retinopathy-related plasma biomarkers in diabetic patientsArchives of Biochemistry and Biophysics, 2013
- Characterisation of the vitreous proteome in proliferative diabetic retinopathyProteome Science, 2012
- Effect of Pigment Epithelium Derived Factor on the Expression of Glutamine Synthetase in Early Phase of Experimental Diabetic RetinopathyOcular Immunology and Inflammation, 2011
- Multi-Modal Proteomic Analysis of Retinal Protein Expression Alterations in a Rat Model of Diabetic RetinopathyPLOS ONE, 2011
- Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factorsExperimental & Molecular Medicine, 2009
- Characterization of the Vitreous Proteome in Diabetes without Diabetic Retinopathy and Diabetes with Proliferative Diabetic RetinopathyJournal of Proteome Research, 2008
- Distribution of Amyloid Precursor Protein and Amyloid-β Immunoreactivity in DBA/2J Glaucomatous Mouse RetinasInvestigative Ophthalmology & Visual Science, 2007
- Current two‐dimensional electrophoresis technology for proteomicsProteomics, 2004